01 5ABBVIE
01 59708371
01 5Blank
01 5Y
01 52033-08-16
Patent Expiration Date : 2033-08-16
US Patent Number : 9708371
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 202811
Patent Use Code : U-1515
Delist Requested :
Patent Use Description : METHOD OF TREATING IRR...
Patent Expiration Date : 2033-08-16
Patent Expiration Date : 2033-08-16
US Patent Number : 9708371
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 202811
Patent Use Code : U-3644
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-08-16
Patent Expiration Date : 2033-08-16
US Patent Number : 9708371
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 202811
Patent Use Code : U-1516
Delist Requested :
Patent Use Description : METHOD OF TREATING CHR...
Patent Expiration Date : 2033-08-16
Patent Expiration Date : 2033-08-16
US Patent Number : 9708371
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 202811
Patent Use Code : U-1516
Delist Requested :
Patent Use Description : METHOD OF TREATING CHR...
Patent Expiration Date : 2033-08-16
Patent Expiration Date : 2033-08-16
US Patent Number : 9708371
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 202811
Patent Use Code : U-1515
Delist Requested :
Patent Use Description : METHOD OF TREATING IRR...
Patent Expiration Date : 2033-08-16
